Course Director: Scott B. Silverman, MD

For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at partnerscpd@partners.org.

You may print individual certificates throughout the year; your cumulative list of sessions attended is accessible on your transcript.


ACCREDITATION

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 CreditTM
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing
Mass General Brigham designates this activity for 1 ANCC contact hour. Nurses should only claim credit commensurate with the extent of their participation in the activity.

 

"Management of Hyperlipidemia"

Upon completion of this activity, participants will be able to:

Understand the MOA, indications for and LDL-C lowering effects of current approved PCSK9 inhibitors

Understand the current status of medications to lower Lp(a)

Understand evidence for/against use of ASA for primary prevention in patients with elevated Lp(a)

Session date: 
11/30/2022 - 12:00pm to 1:00pm EST
Location: 
Massachusetts General Hospital
Boston, MA 02114
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Nursing Contact Hours
  • 1.00 Participation

Please login or register to take this course.
In-hospital series contact
Name: 
Mass General Brigham CPD
Email: 
PartnersCPD@PARTNERS.ORG